PharmaCyte Biotech, Inc. (PMCB)
0.3422
0.00 (0.00%)
USD |
NASDAQ |
Oct 20, 16:00
0.3411
0.00 (0.00%)
After-Hours: 20:00
PharmaCyte Biotech Net Income (Quarterly) : -5.081M for July 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -5.081M |
| April 30, 2026 | -4.393M |
| January 31, 2026 | 0.7469M |
| October 31, 2025 | -7.418M |
| July 31, 2025 | -8.360M |
| April 30, 2025 | 11.75M |
| January 31, 2025 | -3.045M |
| October 31, 2024 | -1.470M |
| July 31, 2024 | 23.42M |
| April 30, 2024 | 1.347M |
| January 31, 2024 | -0.6195M |
| October 31, 2023 | 2.790M |
| July 31, 2023 | -3.183M |
| April 30, 2023 | -0.1263M |
| January 31, 2023 | -0.7641M |
| October 31, 2022 | -1.880M |
| July 31, 2022 | -1.545M |
| April 30, 2022 | -1.423M |
| January 31, 2022 | -0.8113M |
| October 31, 2021 | -0.9797M |
| July 31, 2021 | -1.025M |
| April 30, 2021 | -0.96M |
| January 31, 2021 | -0.7571M |
| October 31, 2020 | -0.9502M |
| July 31, 2020 | -0.8839M |
| Date | Value |
|---|---|
| April 30, 2020 | -0.7504M |
| January 31, 2020 | -0.8753M |
| October 31, 2019 | -1.067M |
| July 31, 2019 | -1.134M |
| April 30, 2019 | -1.139M |
| January 31, 2019 | -0.6763M |
| October 31, 2018 | -1.037M |
| July 31, 2018 | -1.215M |
| April 30, 2018 | -1.296M |
| January 31, 2018 | -2.031M |
| October 31, 2017 | -1.814M |
| July 31, 2017 | -1.688M |
| April 30, 2017 | -1.155M |
| January 31, 2017 | -1.282M |
| October 31, 2016 | -0.9746M |
| July 31, 2016 | -1.032M |
| April 30, 2016 | -1.122M |
| January 31, 2016 | -1.791M |
| October 31, 2015 | -1.636M |
| July 31, 2015 | -1.515M |
| April 30, 2015 | -2.821M |
| January 31, 2015 | -1.458M |
| October 31, 2014 | -4.064M |
| July 31, 2014 | -1.585M |
| April 30, 2014 | -16.47M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 5.081M |
| EPS Diluted (Quarterly) | -0.5389 |
| Enterprise Value | -24.95M |
| Earnings Yield | -701.2% |
| Normalized Earnings Yield | -368.99 |